Abiraterone acetate 250 MG tab 120S
Ended Awarded
- Contract number
- SPE2DB25FRN79
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,702
Award facts
- Contract value 100% obligated
- $13,701.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Abiroterone Acetate 250 mg tablets (120-count) valued at $13,701.92. This firm fixed-price delivery order is classified as non-competitive and will be completed by July 22, 2025. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of delivery orders with the Defense Logistics Agency covering brand-name and generic medications across multiple therapeutic domains. The company's federal contracting demonstrates consistent capability to fulfill diverse pharmaceutical supply requirements through open competition and firm fixed-price mechanisms, supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This particular delivery order for Abiroterone Acetate—a prostate cancer treatment medication—exemplifies the company's role in supplying specialized pharmaceutical commodities to support military healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FRN79?
SPE2DB25FRN79 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FRN79 worth?
The government has obligated $13,702 on SPE2DB25FRN79.
Is contract SPE2DB25FRN79 an order under another contract?
Yes. SPE2DB25FRN79 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FRN79 competed?
The extent of competition for SPE2DB25FRN79 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award